Bayer Stock Today

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>BAY</div>
Bayer Aktienges is trading at 14.25 as of the 3rd of April 2020; that is 1.25% down since the beginning of the trading day. The stock's open price was 14.43. Bayer Aktienges has 45 percent ods of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 30 days. Equity ratings for Bayer Aktienges Ads are calculated based on the Macroaxis scoring framework. The performance scores are derived for the period starting the 4th of January 2020 and ending today, the 3rd of April 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance0 100 

Bayer Aktienges Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on BATS Exchange in USA. more on Bayer Aktienges
Legal NameBayer Aktienges Ads
CEOLiam CondonView All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Bayer Aktienges Ads
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Bayer Aktienges Ads [BAYRY] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 57.05 B. Bayer Aktienges Ads classifies itself under Healthcare sector and is part of Drug Manufacturers?General industry. The entity has 3.93 B outstanding shares of which 427.05 K shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. BAYER AKTIENGES A has accumulated about 7.51 B in cash with 2.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92.
Check Bayer Aktienges Probability Of Bankruptcy

Ownership Allocation (%)

Bayer Stock Price Odds Analysis

Odds Down 14.25HorizonTargetOdds Up 14.25
7.84%30 days
Based on normal probability distribution, the odds of Bayer Aktienges to move above current price in 30 days from now is about 92.13 (This Bayer Aktienges Ads probability density function shows the probability of Bayer Aktienges OTC Stock to fall within a particular range of prices over 30 days) .

Bayer Aktienges Ads Risk Profiles

Bayer Stock Against Markets

Did you try this?

Run Fundamentals Comparison Now


Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Bayer Aktienges Upcoming and Recent Events

Bayer Aktienges Company Earnings Announcements Dates

Upcoming Quarterly Earning Report22nd of February 2017
Next Earnings Report25th of April 2017
Next Fiscal Quarter End31st of December 2016
Next Fiscal Year End22nd of February 2017
Last Quarter Report Date30th of September 2016
Last Earning Anouncement Date31st of December 2015

Bayer Aktienges Corporate Management

Heike Hausfeld Member of the Supervisory Board
Peter Hausmann Member of the Supervisory Board
Heiko Schipper Member of the Management Board, Head of the Consumer Health Division
Thomas Fischer Member of the Supervisory Board
Detlef Rennings Member of the Supervisory Board
Continue to Trending Equities. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page